Klingman & Associates’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
Other funds holding BME
SWP
FAAS
Klingman & Associates's BME Position: Q4 2016 in Review
Klingman & Associates sold out of BlackRock Health Sciences Trust (BME) in Q4 2016, closing a stake of 200 shares — an estimated $7K sold.
Klingman & Associates first reported a position in BME in Q4 2014 and held it in 7 quarters. The position peaked at $9K in Q2 2015. 34 funds tracked by Wall St. Rank hold BME as of Q4 2016.
- Klingman & Associates reported no remaining BlackRock Health Sciences Trust position as of Q4 2016 after selling out during the quarter.
- Klingman & Associates sold 200 BlackRock Health Sciences Trust shares in Q4 2016, an estimated $7K.
- Klingman & Associates first reported a position in BlackRock Health Sciences Trust in Q4 2014 and held it in 7 quarters.
- Klingman & Associates's BlackRock Health Sciences Trust position peaked at $9K in Q2 2015.
- 34 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2016.
Based on Klingman & Associates's 13F filing for Q4 2016, filed 26 Jan 2017.